Silverback Therapeutics Q2 EPS $(0.70) Up From $(9.65) YoY
Silverback Therapeutics (NASDAQ:SBTX) reported quarterly losses of $(0.70) per share. This is a 92.75 percent increase over losses of $(9.65) per share from the same period last year.
Silverback Therapeutics (NASDAQ:SBTX) reported quarterly losses of $(0.70) per share. This is a 92.75 percent increase over losses of $(9.65) per share from the same period last year.